Top compounds associated with response to GTF2IRD2


Feature Type Standardized
Nominal ANOVA
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.17 8e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA fingolimod CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 0.0002
mRNA AZD-7545 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.11 0.0005
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.11 0.0006
Download CSV